APA aipamena

Krieger, T., Pearson, I., Bell, J., Doherty, J., & Robbins, P. (2020). Targeted literature review on use of tumor mutational burden status and programmed cell death ligand 1 expression to predict outcomes of checkpoint inhibitor treatment. Diagn Pathol.

Chicago Style aipamena

Krieger, Tina, Isobel Pearson, Judith Bell, Jim Doherty, and Paul Robbins. "Targeted Literature Review On Use of Tumor Mutational Burden Status and Programmed Cell Death Ligand 1 Expression to Predict Outcomes of Checkpoint Inhibitor Treatment." Diagn Pathol 2020.

MLA aipamena

Krieger, Tina, et al. "Targeted Literature Review On Use of Tumor Mutational Burden Status and Programmed Cell Death Ligand 1 Expression to Predict Outcomes of Checkpoint Inhibitor Treatment." Diagn Pathol 2020.

Kontuz: berrikusi erreferentzia hauek erabili aurretik.